Think you’re protected from shingles? What doctors want older adults to know
If you were vaccinated against shingles before 2017, you might not be as protected as you think.
A new vaccine offers enhanced protection against shingles, a common yet serious viral disease that causes a painful, blistering rash and can lead to skin infections, vision problems, and long-term nerve pain. Approved in late 2017, Shingrix is recommended for adults 50 and older. It provides a much-needed upgrade in shingles prevention.
Shingles is caused by the same virus responsible for chickenpox, which can remain dormant in the body and reactivate later in life. The condition often begins with a burning, tingling, or numbing sensation, followed by a painful rash that develops on one side of the body a few days later. Fever, headache, and fatigue can also occur. While the rash itself typically clears within weeks, some individuals experience nerve pain that persists for months or even years.
The risk of shingles increases with age or stress, which can weaken the immune system. While the vaccine isn’t recommended for those under 50, younger individuals can reduce their risk by managing stress, eating a balanced diet, and prioritizing good sleep habits.
Why older adults should consider revaccination
Before Shingrix, most adults were vaccinated with Zostavax, typically starting at age 60. However, Shingrix, which is not a live vaccine, offers stronger and longer-lasting protection and is recommended beginning at age 50. Even those who previously received Zostavax are advised to get revaccinated with Shingrix, as well as those who have already had shingles, since the condition can occasionally flare up again.
The Shingrix vaccine is administered in two doses, spaced two to six months apart. Studies have shown that it is more than 90% effective at preventing shingles, making it the preferred vaccine according to national immunization guidelines.
While the vaccine can cause minor side effects, such as flu-like symptoms, fatigue, or mild headaches, these are short-lived and far less severe than the potential pain of shingles. Singrix is covered under Medicare Part D, making it an accessible option for most eligible adults.
If you’re 50 or older, this vaccine can help you avoid the pain and complications of shingles, allowing you to focus on living life to the fullest.
